0.9785
4.07%
-0.0415
Finanzdaten der Biofrontera Inc-Aktie (BFRI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
25.33%
7.912
|
10.60 | 8.896 | 5.848 | 8.733 |
Operating Expenses |
7.48%
13.38
|
14.46 | 13.52 | 14.55 | 14.22 |
Interest Income/Expense |
4,047%
1.421
|
-0.036 | 0.142 | 0.079 | 0.002 |
Benefits Costs and Expenses |
159.30%
18.35
|
7.076 | 15.24 | 15.67 | 16.21 |
Costs And Expenses |
159.30%
18.35
|
7.076 | 15.24 | 15.67 | 16.21 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
41.45%
-5.467
|
-3.865 | -4.62 | -8.699 | -5.492 |
Net Interest Income/Expense |
563.68%
-1.407
|
-0.212 | -0.142 | -0.079 | -0.035 |
Nonoperating Income/Loss
|
167.29%
-4.969
|
7.385 | -1.721 | -1.124 | -1.981 |
Income/Loss Before Equity Method Investments |
-10.44
|
- | - | - | - |
Income/Loss From Equity Method Investments |
0.003
|
- | - | - | - |
Income/Loss From Continuing Operations Before Tax |
396.48%
-10.44
|
3.52 | -6.341 | -9.823 | -7.473 |
Income Tax Expense/Benefit |
116.67%
0.001
|
-0.006 | 0.001 | - | 0.005 |
Income/Loss From Continuing Operations After Tax |
396.00%
-10.44
|
3.526 | -6.342 | -9.823 | -7.478 |
Net Income/Loss
|
396.00%
-10.44
|
3.526 | -6.342 | -9.837 | -7.478 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1,711%
3.6236
|
0.20 | 1.3668 | 1.3607 | 26.70 |
Diluted Average Shares |
1,711%
3.6236
|
0.20 | 1.3668 | 1.3607 | 26.70 |
Basic Earnings Per Share |
163.30%
-2.88
|
4.55 | -4.64 | -7.23 | -0.28 |
Diluted Earnings Per Share |
163.30%
-2.88
|
4.55 | -4.64 | -7.23 | -0.28 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):